What You Should Know:
– ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI’s Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights to accelerate clinical development in precision…
Continue Reading
Healthcare data company ConcertAI announced a multi-year agreement with pharmaceutical and biotechnology giant Bayer to utilize ConcertAI’s Translational360 and AI SaaS offerings.The offerings use AI and machine learning-acquired insights to speed up clinical development…
Continue Reading
ConcertAI will Invest in CancerLinQ to Provide its Members with Upgraded Quality Reporting, Industry-Leading Real-World Data, and AI-Powered Solutions for Accelerated Clinical Trials in a Multi-Year Cooperation Agreement with ASCO
ConcertAI today announced the acquisition…
What You Should Know:
– ConcertAI, a developer of AI-powered healthcare solutions, announced today the acquisition of CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO).
– This strategic move will significantly enhance and…
Continue Reading
